Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls

HIGHLIGHTS

  • who: Yuzhen Shi from the The State University of New Jersey, United States have published the article: Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls, in the Journal: (JOURNAL)
  • what: This study aimed to evaluate the effectiveness and safety of GnRHa combined with rhGH therapy in girls with ICPP. __EQUATION__whereas this study has the advantage of including multiple time points of 3, 6, 9, 12, 18, 24 and 30 months after treatment, reflecting the changes in various indicators during the dosing period more dynamically and continuously . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?